A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Nelfinavir (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 15 Mar 2017 New trial record
- 13 Mar 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Oct 2019.
- 13 Mar 2017 Status changed from suspended to recruiting.